PALI

Palisade Bio, Inc.NASDAQHealthcare

$1.89+2.12%ClosedMarket Cap: $313.5M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-05-13	Brookline Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-0.26	$27.9M	5
Fri Dec 31	$-0.30	$47.7M	6
Sun Dec 31	$-0.50	$121.5M	5
Mon Dec 31	$-0.45	$415.3M	1

PALI | Palisade Bio, Inc. Analyst Ratings & Price Target - InvestLog